Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-0186

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-0186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Atorvastatin Calcium 20mg 70518 0186 01)

Mm2 (Atorvastatin Calcium 20mg 70518 0186 01)
Label for Atorvastatin Calcium 20 mg film-coated tablets, quantity 90, labeled for oral use. The label includes the product NDC 70518-0186-01, manufacturer Apotex Corp., and repackager RemedyRepack Inc. It instructs to see package insert for directions and advises storage conditions.*
FDA Label Image

Mm3 (Atorvastatin Calcium 20mg 70518 0186 02)

Mm3 (Atorvastatin Calcium 20mg 70518 0186 02)
Label for Atorvastatin Calcium 20 mg oral tablets, quantity of 28 tablets. The label includes the NDC 70518-0186-02 and manufacturer information from Apotex Corp., Weston, FL. It notes the product is repackaged by RemedyRepack Inc., Indiana, PA, with storage instructions and a QR code present.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph showing cumulative incidence percentage over time in years comparing Atorvastatin and Placebo groups. The graph includes hazard ratio (HR=0.64) with confidence interval (0.50-0.83) and a p-value of 0.0005, indicating a statistical comparison between the two lines representing Atorvastatin and Placebo.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A Kaplan-Meier curve showing cumulative hazard percentage over time for placebo and atorvastatin groups, plotted through four years of follow-up. The solid line represents atorvastatin, and the dashed line represents placebo, with the x-axis showing years to first primary endpoint and the y-axis the cumulative hazard percentage.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A graph depicting the percentage of subjects experiencing an event over time, comparing Atorvastatin 10 mg (dashed line) to Atorvastatin 80 mg (solid line) with the x-axis representing time to first major cardiovascular endpoint in years and the y-axis showing the percentage of subjects experiencing the event. A hazard ratio (HR) and p-value are noted on the graph.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Atorvastatin Calcium 20 mg film-coated tablets, packaged in a quantity of 30. The label indicates the manufacturer as Apotex Corp., Weston, FL, with repackaging by RemedyRepack Inc. It includes storage instructions and a note to see the package insert for directions. The presence of QR codes is noted on the label.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure diagram of atorvastatin calcium, showing the molecular arrangement including calcium ion (Ca2+) coordination and atorvastatin molecule components, consistent with the active ingredient atorvastatin calcium in the 20 mg film-coated tablet by RemedyRepack Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.